Dr. Charles Raison

Researchers from Emory University, the University of Wisconsin-Madison and UC-Berkeley have identified a significant opportunity for psilocybin-assisted therapy in the U.S. mental healthcare landscape. As U.S. News reported, if approved by the FDA, psilocybin could be used to treat depression, with...

A new study published in the peer-review journal Cell looks at a novel compound capable of providing some of the therapeutic properties of psychedelics without hallucinations. The paper, co-authored by Delix Therapeutics co-founder and chief scientific officer David Olson, Ph.D.,...